How Will Payers Manage The High Cost Of Combinations Of New Oncology Agents, As Many Of These Therapies Become The Preferred Treatment Options To Optimize Patient Outcomes?
May 1, 2018, 00:00
10.1016/j.jval.2018.04.250
https://www.valueinhealthjournal.com/article/S1098-3015(18)30550-3/fulltext
Title :
How Will Payers Manage The High Cost Of Combinations Of New Oncology Agents, As Many Of These Therapies Become The Preferred Treatment Options To Optimize Patient Outcomes?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30550-3&doi=10.1016/j.jval.2018.04.250
First page :
Section Title :
Open access? :
No
Section Order :
1121